Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

MG Crespo‐Leiro, M Metra, LH Lund… - European journal of …, 2018 - Wiley Online Library
This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Dilated cardiomyopathy

RG Weintraub, C Semsarian, P Macdonald - The Lancet, 2017 - thelancet.com
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and
contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal …

Intrapericardial left ventricular assist device for advanced heart failure

JG Rogers, FD Pagani, AJ Tatooles… - … England Journal of …, 2017 - Mass Medical Soc
Background Mechanical circulatory support with a left ventricular assist device (LVAD) is an
established treatment for patients with advanced heart failure. We compared a newer LVAD …

2019 EACTS Expert Consensus on long-term mechanical circulatory support

EV Potapov, C Antonides… - European Journal of …, 2019 - academic.oup.com
Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

HVAD: the ENDURANCE supplemental trial

CA Milano, JG Rogers, AJ Tatooles, G Bhat… - JACC: Heart Failure, 2018 - jacc.org
Objectives: The aim of this study was to prospectively evaluate the impact of blood pressure
management on stroke rates in patients receiving the HeartWare HVAD System …

Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes

F Gustafsson, JG Rogers - European journal of heart failure, 2017 - Wiley Online Library
Despite improvements in pharmacological therapy and pacing, prognosis in advanced heart
failure (HF) remains poor, with a 1‐year mortality of 25–50%. While heart transplantation …

[HTML][HTML] An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial

SS Najjar, MS Slaughter, FD Pagani… - The Journal of Heart and …, 2014 - Elsevier
Background The HeartWare left ventricular assist device (HVAD, HeartWare Inc,
Framingham, MA) is the first implantable centrifugal continuous-flow pump approved for use …

Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the …

JD Estep, RC Starling, DA Horstmanshof… - Journal of the American …, 2015 - jacc.org
Background: Data for left ventricular assist devices (LVADs) in patients with noninotrope-
dependent heart failure (HF) are limited. Objectives: The goal of this study was to evaluate …

Heart failure with reduced ejection fraction

MW Bloom, B Greenberg, T Jaarsma… - Nature reviews Disease …, 2017 - nature.com
Heart failure is a global public health problem that affects more than 26 million people
worldwide. The global burden of heart failure is growing and is expected to increase …

Left ventricular assist devices: synergistic model between technology and medicine

JJ Han, MA Acker, P Atluri - Circulation, 2018 - Am Heart Assoc
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …